University of Calgary researchers found that removing a single gene allows the immune system to recognize and attack colon cancer cells, achieving complete tumor elimination in mice when combined with immunotherapy. This is a legitimate breakthrough in preclinical research, though mouse models do not always translate to human effectiveness — the next step is testing whether the approach works in human trials. The gene target could potentially become a new therapeutic strategy if it proves safe and effective in people.